Best fit for this contractDavis-Bacon
MD20260082 (Rev 0)Match signal: state matchOpen WD
Published Jan 02, 2026Maryland • Anne Arundel
Rate
Base $47.92Fringe $24.44
Rate
Base $37.50Fringe $14.78
+84 more occupation rates available in the full WD.
Freeze Dried Plasma FDP Emergency Use Authorization or FDA Licensed Product
Solicitation: Not available
Notice ID: 6b2216b5bf0ef738378c04fe72a6506a
Federal opportunity from Public Agency. Place of performance: MD.
Market snapshot
Baseline awarded-market signal across all contracting (sample of 400 recent awards; refreshed periodically).
12-month awarded value
$903,760,926
Sector total $903,760,926 • Share 100.0%
Live
Median
$191,909
P10–P90
$26,352–$2,550,765
Volatility
Volatile200%
Market composition
NAICS share of sector
A simple concentration signal, not a forecast.
100.0%
share
Momentum (last 3 vs prior 3 buckets)
+100%($903,760,926)
Deal sizing
$191,909 median
Use as a pricing centerline.
Live signal is computed from awarded notices already observed in the system.
Signals shown are descriptive of observed awards; not a forecast.
Related hubs & trends
Navigate the lattice: hubs for browsing, trends for pricing signals.
Live POP
Place of performance
MD, US
State: US
Contracting office
Not listed
Applicable Wage Determinations
SAM WDOL references matched to this opportunity's location and scope language.
View more for this contract3 more WD matches and 84 more rate previews.↓
View more for this contract
3 more WD matches and 84 more rate previews.
Davis-BaconBest fitstate match
MD20260082 (Rev 0)Published Jan 02, 2026Maryland • Anne Arundel
Rate
Base $47.92Fringe $24.44
Rate
Base $37.50Fringe $14.78
Rate
Base $34.41Fringe $14.49
+83 more occupation rates in this WD
Davis-Baconstate match
MD20260120 (Rev 0)Published Jan 02, 2026Maryland • Montgomery
Rate
Base $47.92Fringe $24.44
Rate
Base $37.50Fringe $14.78
Rate
Base $34.41Fringe $14.49
+77 more occupation rates in this WD
Davis-Baconstate match
MD20260041 (Rev 0)Published Jan 02, 2026Maryland • Howard
Rate
Base $37.50Fringe $14.78
Rate
Base $34.41Fringe $14.49
Rate
Base $34.41Fringe $14.49
+59 more occupation rates in this WD
Davis-Baconstate match
MD20260061 (Rev 0)Published Jan 02, 2026Maryland • Baltimore City
Rate
Base $34.12Fringe $14.64
Rate
Base $21.60Fringe $0.00
Rate
Base $19.41Fringe $3.11
+14 more occupation rates in this WD
Point of Contact
Not available
Agency & Office
Department
Public Agency
Agency
Not available
Subagency
Not available
Office
Procurement
Contracting Office Address
Not available
Description
Freeze Dried Plasma FDP Emergency Use Authorization or FDA Licensed Product
Files
Files size/type shown when available.
No downloadable attachments detected for this notice.
BidPulsar Analysis
A practical, capture-style breakdown of fit, requirements, risks, and next steps.
Updated: Mar 15, 2026
Client-ready brief
Executive summary
low confidencegpt 5.2
This notice, titled "Freeze Dried Plasma FDP Emergency Use Authorization or FDA Licensed Product," indicates a buyer need for freeze dried plasma (FDP) that is either covered under an Emergency Use Authorization (EUA) or is an FDA-licensed product. The agency is listed only as "Public Agency," with no solicitation number, dates, place of performance, or attachments provided. Based on the limited text, this appears to be an early market research/interest signal or a minimal synopsis rather than a complete solicitation. A viable response strategy depends on confirming whether the buyer is seeking product procurement, distribution capability, and what evidence of FDA status must be submitted.
Freeze Dried PlasmaFDPEmergency Use AuthorizationEUAFDA licensedblood productplasmahemostatic resuscitation
What the buyer is trying to do
Identify and potentially procure Freeze Dried Plasma (FDP) that is either authorized for emergency use (EUA) or FDA licensed, likely for emergency/clinical use where regulatory status is central to acceptability.
Who should pursue this
- Manufacturers of Freeze Dried Plasma (FDP) products that are FDA licensed.
- Manufacturers/distributors of FDP with an active Emergency Use Authorization (EUA) applicable to the intended use.
- Prime vendors with proven ability to supply regulated blood products and provide required regulatory documentation tied to EUA/licensure.
Work breakdown
- Confirm your FDP offering regulatory pathway: EUA status or FDA-licensed status (and which specific product).
- Prepare regulatory documentation package evidencing EUA letter/authorization details or FDA licensure details as applicable.
- Define product characteristics and logistics: packaging, storage requirements, shelf life, reconstitution requirements, and handling controls (only if requested by the buyer).
- Establish supply and distribution capability: manufacturing source, available inventory, lead times, and delivery model (only if the buyer is procuring now).
- Quality/compliance readiness: lot release documentation, traceability, and labeling consistent with EUA/licensure terms (as applicable).
Response package checklist
- Evidence of FDP regulatory status: EUA documentation or FDA licensure documentation for the specific product.
- Product identification details (exact product name/model) matching the EUA/licensure documentation.
- Supplier/manufacturer authorization (if you are not the manufacturer) demonstrating you are permitted to sell/distribute the product.
- Any available product data sheets/IFU consistent with EUA/licensure terms (submit only if allowed/asked).
- A statement of ability to supply (availability, lead time) if the buyer is requesting procurement rather than information.
Compliance notes
- The notice explicitly limits acceptable products to those with Emergency Use Authorization (EUA) or FDA-licensed status—eligibility hinges on this.
- No NAICS, PSC, set-aside, solicitation number, or submission instructions are provided in the brief; compliance requirements beyond EUA/licensure cannot be determined from the notice text.
Pricing strategy
- No quantity, delivery terms, or pricing structure is provided; do not assume a unit price model without buyer clarification.
- If the buyer requests a quote, ensure pricing aligns with the specific FDP product that matches the EUA/licensure documentation and any associated handling/special shipping needs (if applicable).
Teaming and subs
- If you hold product rights but lack distribution, consider teaming with an established regulated-medical distributor experienced with controlled temperature logistics (only if FDP handling requires it under your product terms).
- If you are a distributor, ensure you have a direct authorization/letter from the manufacturer to avoid disqualification on product authenticity/regulatory provenance.
Risks and watchouts
- Insufficient notice detail: missing submission instructions, deadlines, quantities, delivery locations, and evaluation method increases the risk of misaligned response.
- Regulatory mismatch risk: offering an FDP product whose EUA scope/terms do not match the buyer’s intended use could render the offer nonresponsive.
- Documentation risk: inability to provide clear, current EUA/licensure evidence for the exact product offered may lead to rejection.
Smart questions to ask
- Is this a solicitation, sources sought/RFI, or a market survey?
- What is the required submission format and where should responses be sent (portal/email/address)?
- What is the required FDA status: must it be FDA-licensed, or is EUA acceptable for all intended uses?
- What specific FDP product characteristics are required (dosage/unit configuration, shelf-life minimum, storage conditions, reconstitution time)?
- What quantities, delivery schedule, and delivery locations are anticipated?
- Are distributors allowed to respond, and if so, what manufacturer authorization documentation is required?
- Are there any additional compliance requirements beyond EUA/licensure (e.g., labeling, lot traceability, quality documentation) that must be submitted with the response?
Source coverage notes
Some notices publish limited source detail. Confirm these points before final bid/no-bid decisions.
- Solicitation number/notice type and whether this is an RFI, sources sought, or an active procurement
- Response deadline and submission instructions (where/how to respond)
- Quantity/estimated volume and ordering model
- Delivery locations/place of performance and shipping requirements
- Period of performance or desired delivery timeline
- Required product specifications beyond EUA/FDA status
- Evaluation criteria and required response artifacts/forms
- Any applicable NAICS/PSC and set-aside details
FAQ
How do I use the Market Snapshot?
It summarizes awarded-contract behavior for the opportunity’s NAICS and sector, including a recent pricing band (P10–P90), momentum, and composition. Use it as context, not a guarantee.
Is the data live?
The signal updates as new awarded notices enter the system. Always validate the official award and solicitation details on SAM.gov.
What do P10 and P90 mean?
P10 is the 10th percentile award size and P90 is the 90th percentile. Together they describe the typical spread of award values.